Literature DB >> 25816117

Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats.

Changming Wang1, Xiuping Xuan1, Wenmin Yao2, Guojin Huang1, Junfei Jin2.   

Abstract

The present study aimed to determine whether artesunate has beneficial effects on bleomycin-induced pulmonary fibrosis in rats and to examine the possible mechanisms underlying these effects. All experiments were performed with male Sprague Dawley rats weighing 180-250 g. Animals were randomly divided into four experimental groups that were administered either saline alone, artesunate alone, bleomycin alone or bleomycin + artesunate. Lung histopathology was investigated by hematoxylin and eosin staining and Masson staining. Lung profibrotic molecules were analyzed by reverse transcription polymerase chain reaction, immunoblotting and immunohistochemistry. In rats treated with artesunate, pulmonary fibrosis induced by bleomycin was significantly reduced. Administration of artesunate significantly improved bleomycin-induced morphological alterations. Profibrotic molecules, including transforming growth factor-β1, Smad3, heat shock protein 47, α-smooth muscle actin and collagen type I were also reduced by artesunate. These findings suggest that artesunate improves bleomycin-induced pulmonary fibrosis pathology in rats possibly by inhibiting profibrotic molecules associated with pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25816117     DOI: 10.3892/mmr.2015.3500

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?

Authors:  Pawan K Agrawal; Chandan Agrawal; Gerald Blunden
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

2.  First principle study of silver nanoparticle interactions with antimalarial drugs extracted from Artemisia annua plant.

Authors:  Mahmood Akbari; Razieh Morad; Malik Maaza
Journal:  J Nanopart Res       Date:  2020-10-27       Impact factor: 2.253

Review 3.  Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.

Authors:  Dorothy H J Cheong; Daniel W S Tan; Fred W S Wong; Thai Tran
Journal:  Pharmacol Res       Date:  2020-05-13       Impact factor: 7.658

Review 4.  Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics.

Authors:  David Dolivo; Pamela Weathers; Tanja Dominko
Journal:  Acta Pharm Sin B       Date:  2020-09-08       Impact factor: 11.413

5.  Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-γ/TGF-β1/Smad2/3 signalling pathway.

Authors:  Kunming Pan; Juanjuan Lu; Yun Song
Journal:  Respir Res       Date:  2021-03-23

Review 6.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

7.  Role of artesunate in TGF‑β1‑induced renal tubular epithelial‑mesenchymal transdifferentiation in NRK‑52E cells.

Authors:  Yaqian Zhang; Huanhuan Li; Jiajun Zhu; Tiantian Wei; Yingxian Peng; Ran Li; Rui Xu; Mei Li; Anzhou Xia
Journal:  Mol Med Rep       Date:  2017-10-05       Impact factor: 2.952

8.  Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway.

Authors:  Yujuan Liu; Guojin Huang; Biwen Mo; Changming Wang
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

9.  Artemisia annua: Trials are needed for COVID-19.

Authors:  Faiz Ul Haq; Muhammad Roman; Kashif Ahmad; Saeed Ur Rahman; Syed Murtaza Ali Shah; Naveed Suleman; Sami Ullah; Iftekhar Ahmad; Wajahat Ullah
Journal:  Phytother Res       Date:  2020-05-27       Impact factor: 6.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.